Riskpilot← Back to searchSign inGet full accessNUTRAQ NORWAY AS
ASActiveOrg 993905607Sjølyst Plass 3, 0278 OsloRetail sale of other food · NACE 4727Est. 20090 employees
Revenue 2024
NOK 217,2M
-10% vs 2023
EBITDA margin
22.7%
+26% vs 2023
Equity ratio
40.3%
Financial strength
Net profit 2024
NOK 73,3M
+96% vs 2023
| Revenue | NOK 217,2M | -10% |
| EBITDA | NOK 49,3M | +26% |
| Net profit | NOK 73,3M | +96% |
| Total assets | NOK 111,2M | +31% |
| Equity | NOK 44,9M | +221% |
| Employees | 0 | — |
Legal name
NUTRAQ NORWAY AS
Org number
993905607
Legal form
Aksjeselskap
NACE code
4727 · Retail sale of other food
Founded
1. april 2009
Share capital
NOK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap. Daglig leder og styrets leder i fellesskap.
Company purpose
Øke kunnskapen om vitaepro, antioksidanter og relaterte produkter ved å drive sponsoraktiviteter og informasjonsvirksomhet basert på saklig og vitenskapelig grunnlag samt virksomhet som står i forbindelse med dette, herunder deltagelse i andre selskap med lignende virksomhet.
Address
Sjølyst Plass 3, 0278 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2009 | 2010 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 182 504 | 120 875 | 0 | 0 | 209 952 | 268 294 | 238 922 | 220 237 | 219 061 | 233 488 | 176 746 | 96 615 | 218 508 | 240 348 | 217 199 |
| Staff expenses | −13 110 | −10 097 | −0 | −0 | −8 680 | −7 685 | −8 606 | −8 327 | −9 683 | −11 111 | −4 953 | −3 462 | −927 | −2 912 | −2 411 |
| EBITDA | 28 417 | 23 285 | 0 | 0 | 39 142 | 57 937 | 56 737 | 55 915 | 42 288 | 52 582 | 88 681 | 12 867 | 17 090 | 39 240 | 49 258 |
| Depreciation & amort. | −39 | −0 | −0 | −0 | −4 645 | −4 645 | −4 645 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 28 378 | 23 285 | 0 | 0 | 34 497 | 53 292 | 52 092 | 55 915 | 42 288 | 52 582 | 88 681 | 12 867 | 17 090 | 39 240 | 49 258 |
| Net financials | 144 | 111 | 0 | 0 | −6 801 | −1 012 | −7 | 3 876 | 836 | −855 | 3 150 | −702 | 8 459 | 7 177 | 36 047 |
| Profit before tax | 28 522 | 23 396 | 0 | 0 | 27 696 | 52 280 | 52 085 | 59 790 | 43 124 | 51 727 | 91 831 | 12 165 | 25 549 | 46 417 | 85 305 |
| Tax | 8 018 | 6 314 | −0 | −0 | 7 478 | 14 103 | 13 016 | 14 442 | 9 922 | 11 381 | 20 213 | 2 677 | 4 471 | 8 955 | 11 985 |
| Net profit | 20 505 | 17 082 | 0 | 0 | 20 218 | 38 177 | 39 069 | 45 348 | 33 202 | 40 345 | 71 619 | 9 488 | 21 077 | 37 462 | 73 321 |
| Item | 2009 | 2010 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 52 140 | 44 065 | — | — | 81 533 | 129 337 | 103 322 | 55 099 | 79 458 | 93 504 | 159 263 | 140 274 | 61 899 | 85 234 | 111 246 |
| Equity | 17 300 | 20 585 | — | — | 11 551 | 6 124 | 6 043 | 4 825 | 7 855 | 48 200 | 111 984 | 103 486 | 13 701 | 13 999 | 44 878 |
| Long-term debt | 0 | 0 | 0 | 0 | 6 | 200 | 167 | 97 | 0 | 0 | 11 885 | 9 489 | 8 614 | 6 996 | 7 777 |
| Short-term debt | 34 840 | 22 831 | 0 | 0 | 69 976 | 123 013 | 97 112 | 50 177 | 71 604 | 45 304 | 35 394 | 27 299 | 39 584 | 64 239 | 58 591 |
| Total debt | 34 840 | 23 481 | 0 | 0 | 69 982 | 123 213 | 97 279 | 50 274 | 71 604 | 45 304 | 47 279 | 36 788 | 48 198 | 71 235 | 66 368 |
EBITDA margin
22.7%
This company
15.8%
Market median
+44% vs market
20092024
Equity ratio
40.3%
This company
38.2%
Market median
+5% vs market
20092024
Return on equity
163.4%
This company
18.4%
Market median
+788% vs market
20092024
Net profit margin
33.8%
This company
8.1%
Market median
+317% vs market
20092024
Asset turnover
1.95×
This company
1.12×
Market median
+74% vs market
20092024
Debt / equity
1.48×
This company
0.62×
Market median
-139% vs market
20092024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — | |
| Chairman | 2025 | — | — | |
| Chairman | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Nutraq As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Orkla Asa
NUTRAQ NORWAY AS Board members of NUTRAQ NORWAY AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marius Fladvad Størdal | Board of Directors | 0 companies |
| John Sebastian Schmidt Slørdahl | Chairman | 0 companies |
| Gustaf Solerød Christensen | Chairman | 0 companies |